| 摘要 |
The invention relates to pharmaceutical formulations comprising a dry extract of <i>Galphimia glauca</i> for treating anxiety, in which the active agents are compounds known as galphimines A, B and E. The method of obtaining said extract significantly increases the concentration of the active principles (concentration of up to 50 times greater than with previous methods), resulting in a greater anxiolytic effect and enabling pharmaceutical presentation forms which are smaller than those proposed in the prior art, by capsule or coated tablet, which are more effective and user-friendly for patients. The pharmaceutical formulation to which the invention relates has a better anxiolytic effect than extracts disclosed in the prior art, without the side effects of the drugs currently used in anxiety treatments.
|
